Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01731912 · ClinicalTrials.gov registry record · NA
Degarelix Acetate Before and During Radiation Therapy in Treating Patients With Prostate Cancer
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT01731912 is a NA study that has completed, run by University of Washington. The registered enrollment target is 16 participants.
The verdict
NCT01731912, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
This pilot clinical trial studies how well degarelix acetate before and during radiation therapy works in treating patients with prostate cancer. Androgens can cause the growth of prostate cancer cells. Drugs, such as degarelix acetate, may lessen the amount of androgens made by the body. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Giving degarelix acetate together with radiation therapy may work better in treating prostate cancer.
Interventions
- RADIATION External Beam Radiation Therapy
- OTHER Laboratory Biomarker Analysis
- DRUG Degarelix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2013-05 |
| Est. Completion | 2016-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01731912
The ClinicalTrials.gov registry entry for NCT01731912 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which External Beam Radiation Therapy is the first listed.
NCT01731912 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01731912 about?
NCT01731912 is a clinical study titled "Degarelix Acetate Before and During Radiation Therapy in Treating Patients With Prostate Cancer". This pilot clinical trial studies how well degarelix acetate before and during radiation therapy works in treating patients with prostate cancer. Androgens can cause the growth of prostate cancer cells. Drugs, such as degarelix acetate, may lessen the amount of androgens made by the body. Radiation ...
What is the current status of trial NCT01731912?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2013-05. Estimated completion is 2016-09.
What interventions are being tested in trial NCT01731912?
The interventions under investigation include: External Beam Radiation Therapy (RADIATION), Laboratory Biomarker Analysis (OTHER), Degarelix (DRUG).
Who is sponsoring clinical trial NCT01731912?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.